دورية أكاديمية

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

التفاصيل البيبلوغرافية
العنوان: Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
المؤلفون: Amusu, Senate, Ayuk, Leo, Bilong, Catherine, Boahen, Owusu, Camara, Makhtar, Cheick Haidara, Fadima, Coly, Daouda, Dièye, Siry, Dosoo, David, Ekedi, Melanie, Eneida Almeida Dos Santos, Irma, Kaali, Seyram, Kokogho, Afoke, Levine, Myron, Opoku, Nick, Owusu-Agyei, Seth, Pitmang, Simon, Sall, Fatima, Seydi, Moussa, Sztein, Marcelo, Tejiokem, Mathurin, Traore, Awa, Vernet, Marie-Astrid, Yawson, Abena Kunadu, Tapia, Milagritos D *, Sow, Samba O, Ndiaye, Birahim P, Mbaye, Khardiata D, Thiongane, Aliou, Ndour, Cheikh T, Mboup, Souleymane, Ake, Julie A, Keshinro, Babajide, Akintunde, Gideon A, Kinge, Thompson N, Vernet, Guy, Bigna, Jean Joel, Oguche, Stephen, Koram, Kwadwo A, Asante, Kwaku P, Hogrefe, Wayne R, Günther, Stephan, Naficy, Abdi, De Ryck, Iris, Debois, Muriel, Bourguignon, Patricia, Jongert, Erik, Ballou, William R, Koutsoukos, Marguerite, Roman, François
المصدر: In The Lancet Infectious Diseases June 2020 20(6):707-718
قاعدة البيانات: ScienceDirect
الوصف
تدمد:14733099
DOI:10.1016/S1473-3099(20)30016-5